OncoNano Medicine is developing a new class of pH-activated compounds that digitalize and exploit the variability of pH in disease. pH variability is a proven, simple, and effective identifier of diseased tissue providing a foundation for the development of a broad range of highly targeted therapeutics and imaging agents.

Biotechnology

OncoNano Medicine

Kathy Rath

Matthew Head

Tian Zhao

Don Kruppa

Kartik Krishnan

Ruolan Han

Leadership Team

Regulatory and Compliance Team

Finance and Operations Team

Research and Development Team

��

Teams at OncoNano Medicine

Leadership Team

Regulatory and Compliance Team

Finance and Operations Team

Research and Development Team

��������

Teams at OncoNano Medicine

Leadership Team

Regulatory and Compliance Team

Finance and Operations Team

Research and Development Team

��